What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience
Uterine serous carcinoma accounts for 3–10% of endometrial cancers, but it is the most lethal histopathological subtype. The molecular characterization of endometrial carcinomas has allowed novel therapeutic approaches for these patients. We undertook a retrospective analysis of patients with uterin...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2021-11-01
|
| Collection: | Current Oncology |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/1718-7729/28/6/410 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|